Drug Type Inactivated vaccine, Therapeutic vaccine |
Synonyms |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | - | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | - | |
Bladder Cancer | Preclinical | GB | 30 Jul 2019 | |
Esophageal Carcinoma | Preclinical | GB | 30 Jul 2019 | |
Lung Cancer | Preclinical | GB | 30 Jul 2019 | |
Mesothelioma | Preclinical | GB | 30 Jul 2019 | |
Relapsed Solid Neoplasm | Preclinical | GB | 30 Jul 2019 | |
Head and Neck Neoplasms | Preclinical | BE | 13 Nov 2017 |